Metraipolis › archive › dc_d7d0a53cd78e

Efficacy and safety of Ixazomib-based maintenance therapy after autologous hematopoietic stem cell transplantation in multiple myeloma patients: a… — Europe PMC PMID:41695162

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41695162
DOI
10.3389/fmed.2026.1680704
License (as archived)
solo-consultazione
Archived
2026-11-06T10:50:01.968Z
SHA-256 of the archived text
7a48fa6bf289920faedc007f00f58e227f390289ece1e675e9a1407292802966
Stable URL of this page
https://metraipolis.com/documento/dc_d7d0a53cd78e

How to cite

Efficacy and safety of Ixazomib-based maintenance therapy after autologous hematopoietic stem cell transplantation in multiple myeloma patients: a… — Europe PMC PMID:41695162 — Europe PMC (en), https://europepmc.org/article/MED/41695162 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d7d0a53cd78e (Metraipolis archive dc_d7d0a53cd78e, sha256 7a48fa6bf289920faedc007f00f58e227f390289ece1e675e9a1407292802966)
BibTeX
@misc{dcd7d0a53cd78e,
  title = {Efficacy and safety of Ixazomib-based maintenance therapy after autologous hematopoietic stem cell transplantation in multiple myeloma patients: a… — Europe PMC PMID:41695162},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41695162},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d7d0a53cd78e; sha256 7a48fa6bf289920faedc007f00f58e227f390289ece1e675e9a1407292802966},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41695162. Agents can read the archived copy with the MCP tool read_document.